A detailed history of American Portfolios Advisors transactions in In Mode Ltd. stock. As of the latest transaction made, American Portfolios Advisors holds 208,552 shares of INMD stock, worth $3.75 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
208,552
Holding current value
$3.75 Million
% of portfolio
0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$22.51 - $38.27 $4.69 Million - $7.98 Million
208,552 New
208,552 $6.07 Billion
Q2 2022

Mar 20, 2023

SELL
$20.97 - $37.47 $43,512 - $77,750
-2,075 Reduced 0.99%
206,477 $4.63 Billion
Q1 2022

Mar 21, 2023

BUY
$34.38 - $65.77 $1.32 Million - $2.52 Million
38,295 Added 18.36%
246,847 $9.11 Billion
Q4 2021

Mar 21, 2023

BUY
$63.78 - $97.86 $2.29 Million - $3.51 Million
35,899 Added 17.21%
244,451 $17.3 Billion
Q3 2021

Mar 22, 2023

SELL
$45.58 - $88.24 $3.78 Million - $7.32 Million
-82,980 Reduced 39.79%
125,572 $20 Billion
Q2 2021

Mar 22, 2023

SELL
$34.4 - $48.34 $2.78 Million - $3.91 Million
-80,873 Reduced 38.78%
127,679 $12.1 Billion
Q1 2021

Mar 22, 2023

SELL
$23.17 - $38.3 $2.02 Million - $3.33 Million
-86,968 Reduced 41.7%
121,584 $8.8 Billion
Q4 2020

Mar 22, 2023

SELL
$18.28 - $23.85 $3.76 Million - $4.91 Million
-205,824 Reduced 98.69%
2,728 $130 Million
Q3 2020

Mar 22, 2023

SELL
$12.91 - $18.51 $2.68 Million - $3.84 Million
-207,293 Reduced 99.4%
1,259 $45.6 Million
Q2 2020

Mar 24, 2023

BUY
$9.68 - $17.5 $4,007 - $7,245
414 Added 0.23%
182,674 $5.17 Billion
Q1 2020

Mar 24, 2023

SELL
$7.43 - $24.88 $195,349 - $654,144
-26,292 Reduced 12.61%
182,260 $3.92 Billion
Q4 2019

Mar 24, 2023

SELL
$11.01 - $27.92 $959,334 - $2.43 Million
-87,133 Reduced 41.78%
121,419 $4.76 Billion

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.49B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.